nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—EPHA2—pulmonary artery—mediastinal cancer	0.0604	0.0652	CbGeAlD
Regorafenib—RET—parathyroid gland—mediastinal cancer	0.0441	0.0476	CbGeAlD
Regorafenib—FRK—hematopoietic system—mediastinal cancer	0.0206	0.0223	CbGeAlD
Regorafenib—DDR2—hematopoietic system—mediastinal cancer	0.0185	0.02	CbGeAlD
Regorafenib—FRK—lymphoid tissue—mediastinal cancer	0.0145	0.0157	CbGeAlD
Regorafenib—RET—neck—mediastinal cancer	0.0134	0.0144	CbGeAlD
Regorafenib—DDR2—lymphoid tissue—mediastinal cancer	0.013	0.0141	CbGeAlD
Regorafenib—FGFR2—neck—mediastinal cancer	0.0127	0.0137	CbGeAlD
Regorafenib—RET—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.0123	0.166	CbGpPWpGaD
Regorafenib—DDR2—thyroid gland—mediastinal cancer	0.0118	0.0128	CbGeAlD
Regorafenib—FLT1—neck—mediastinal cancer	0.0118	0.0127	CbGeAlD
Regorafenib—RAF1—neck—mediastinal cancer	0.0117	0.0126	CbGeAlD
Regorafenib—FLT4—hematopoietic system—mediastinal cancer	0.0113	0.0122	CbGeAlD
Regorafenib—MAPK11—thyroid gland—mediastinal cancer	0.0112	0.0121	CbGeAlD
Regorafenib—DDR2—lung—mediastinal cancer	0.0107	0.0116	CbGeAlD
Regorafenib—FGFR1—bronchus—mediastinal cancer	0.01	0.0108	CbGeAlD
Regorafenib—KDR—neck—mediastinal cancer	0.00994	0.0107	CbGeAlD
Regorafenib—RET—hematopoietic system—mediastinal cancer	0.00994	0.0107	CbGeAlD
Regorafenib—FGFR2—hematopoietic system—mediastinal cancer	0.00945	0.0102	CbGeAlD
Regorafenib—EPHA2—hematopoietic system—mediastinal cancer	0.00928	0.01	CbGeAlD
Regorafenib—TEK—hematopoietic system—mediastinal cancer	0.00906	0.00978	CbGeAlD
Regorafenib—KIT—neck—mediastinal cancer	0.00881	0.00952	CbGeAlD
Regorafenib—FLT1—hematopoietic system—mediastinal cancer	0.00875	0.00946	CbGeAlD
Regorafenib—RAF1—hematopoietic system—mediastinal cancer	0.0087	0.0094	CbGeAlD
Regorafenib—PDGFRB—neck—mediastinal cancer	0.00861	0.00929	CbGeAlD
Regorafenib—FGFR1—cardiac atrium—mediastinal cancer	0.00843	0.00911	CbGeAlD
Regorafenib—BRAF—bone marrow—mediastinal cancer	0.00837	0.00905	CbGeAlD
Regorafenib—EPHA2—bronchus—mediastinal cancer	0.00836	0.00903	CbGeAlD
Regorafenib—BRAF—thyroid gland—mediastinal cancer	0.00835	0.00902	CbGeAlD
Regorafenib—PDGFRA—hematopoietic system—mediastinal cancer	0.0082	0.00886	CbGeAlD
Regorafenib—TEK—bronchus—mediastinal cancer	0.00815	0.0088	CbGeAlD
Regorafenib—EPHX2—thyroid gland—mediastinal cancer	0.00798	0.00862	CbGeAlD
Regorafenib—FLT4—lymphoid tissue—mediastinal cancer	0.00793	0.00856	CbGeAlD
Regorafenib—FLT1—bronchus—mediastinal cancer	0.00788	0.00851	CbGeAlD
Regorafenib—RAF1—bronchus—mediastinal cancer	0.00784	0.00846	CbGeAlD
Regorafenib—UGT1A1—hematopoietic system—mediastinal cancer	0.00783	0.00845	CbGeAlD
Regorafenib—KDR—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.0076	0.102	CbGpPWpGaD
Regorafenib—BRAF—lung—mediastinal cancer	0.00759	0.0082	CbGeAlD
Regorafenib—EPHA2—trachea—mediastinal cancer	0.0075	0.0081	CbGeAlD
Regorafenib—KDR—hematopoietic system—mediastinal cancer	0.0074	0.00799	CbGeAlD
Regorafenib—DDR2—lymph node—mediastinal cancer	0.00734	0.00793	CbGeAlD
Regorafenib—EPHX2—lung—mediastinal cancer	0.00725	0.00783	CbGeAlD
Regorafenib—FLT4—bone marrow—mediastinal cancer	0.00722	0.0078	CbGeAlD
Regorafenib—FLT4—thyroid gland—mediastinal cancer	0.0072	0.00778	CbGeAlD
Regorafenib—FGFR1—thyroid gland—mediastinal cancer	0.0071	0.00767	CbGeAlD
Regorafenib—FLT1—trachea—mediastinal cancer	0.00708	0.00764	CbGeAlD
Regorafenib—EPHA2—cardiac atrium—mediastinal cancer	0.00705	0.00761	CbGeAlD
Regorafenib—RAF1—trachea—mediastinal cancer	0.00704	0.0076	CbGeAlD
Regorafenib—RET—lymphoid tissue—mediastinal cancer	0.007	0.00756	CbGeAlD
Regorafenib—MAPK11—lymph node—mediastinal cancer	0.00696	0.00752	CbGeAlD
Regorafenib—TEK—cardiac atrium—mediastinal cancer	0.00688	0.00743	CbGeAlD
Regorafenib—KDR—bronchus—mediastinal cancer	0.00666	0.0072	CbGeAlD
Regorafenib—FLT1—cardiac atrium—mediastinal cancer	0.00665	0.00718	CbGeAlD
Regorafenib—PDGFRA—trachea—mediastinal cancer	0.00663	0.00716	CbGeAlD
Regorafenib—RAF1—cardiac atrium—mediastinal cancer	0.00661	0.00714	CbGeAlD
Regorafenib—KIT—hematopoietic system—mediastinal cancer	0.00656	0.00708	CbGeAlD
Regorafenib—FLT4—lung—mediastinal cancer	0.00654	0.00706	CbGeAlD
Regorafenib—EPHA2—lymphoid tissue—mediastinal cancer	0.00653	0.00706	CbGeAlD
Regorafenib—FGFR1—lung—mediastinal cancer	0.00645	0.00697	CbGeAlD
Regorafenib—PDGFRB—hematopoietic system—mediastinal cancer	0.00641	0.00692	CbGeAlD
Regorafenib—TEK—lymphoid tissue—mediastinal cancer	0.00638	0.00689	CbGeAlD
Regorafenib—RET—thyroid gland—mediastinal cancer	0.00636	0.00687	CbGeAlD
Regorafenib—FLT1—lymphoid tissue—mediastinal cancer	0.00616	0.00666	CbGeAlD
Regorafenib—RAF1—lymphoid tissue—mediastinal cancer	0.00613	0.00662	CbGeAlD
Regorafenib—FGFR1—N-cadherin signaling events—PTPN1—mediastinal cancer	0.00608	0.082	CbGpPWpGaD
Regorafenib—FGFR2—thyroid gland—mediastinal cancer	0.00604	0.00652	CbGeAlD
Regorafenib—KDR—trachea—mediastinal cancer	0.00598	0.00646	CbGeAlD
Regorafenib—EPHA2—thyroid gland—mediastinal cancer	0.00594	0.00641	CbGeAlD
Regorafenib—KIT—bronchus—mediastinal cancer	0.0059	0.00638	CbGeAlD
Regorafenib—TEK—thyroid gland—mediastinal cancer	0.00579	0.00625	CbGeAlD
Regorafenib—PDGFRA—lymphoid tissue—mediastinal cancer	0.00578	0.00624	CbGeAlD
Regorafenib—PDGFRB—bronchus—mediastinal cancer	0.00577	0.00623	CbGeAlD
Regorafenib—ABL1—hematopoietic system—mediastinal cancer	0.00571	0.00617	CbGeAlD
Regorafenib—RAF1—IGF1 pathway—PTPN1—mediastinal cancer	0.00564	0.076	CbGpPWpGaD
Regorafenib—KDR—cardiac atrium—mediastinal cancer	0.00562	0.00607	CbGeAlD
Regorafenib—FLT1—thyroid gland—mediastinal cancer	0.0056	0.00605	CbGeAlD
Regorafenib—RAF1—bone marrow—mediastinal cancer	0.00558	0.00603	CbGeAlD
Regorafenib—RAF1—thyroid gland—mediastinal cancer	0.00557	0.00601	CbGeAlD
Regorafenib—FGFR2—lung—mediastinal cancer	0.00549	0.00593	CbGeAlD
Regorafenib—EPHA2—lung—mediastinal cancer	0.00539	0.00582	CbGeAlD
Regorafenib—KIT—trachea—mediastinal cancer	0.0053	0.00573	CbGeAlD
Regorafenib—TEK—lung—mediastinal cancer	0.00526	0.00568	CbGeAlD
Regorafenib—PDGFRA—thyroid gland—mediastinal cancer	0.00525	0.00567	CbGeAlD
Regorafenib—KDR—lymphoid tissue—mediastinal cancer	0.00521	0.00563	CbGeAlD
Regorafenib—BRAF—lymph node—mediastinal cancer	0.00519	0.00561	CbGeAlD
Regorafenib—PDGFRB—trachea—mediastinal cancer	0.00518	0.00559	CbGeAlD
Regorafenib—ABL1—bronchus—mediastinal cancer	0.00514	0.00555	CbGeAlD
Regorafenib—FLT1—lung—mediastinal cancer	0.00508	0.00549	CbGeAlD
Regorafenib—RAF1—lung—mediastinal cancer	0.00506	0.00546	CbGeAlD
Regorafenib—PDGFRB—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.00503	0.0677	CbGpPWpGaD
Regorafenib—EPHX2—lymph node—mediastinal cancer	0.00496	0.00536	CbGeAlD
Regorafenib—PDGFRB—cardiac atrium—mediastinal cancer	0.00486	0.00525	CbGeAlD
Regorafenib—PDGFRA—lung—mediastinal cancer	0.00476	0.00515	CbGeAlD
Regorafenib—KDR—bone marrow—mediastinal cancer	0.00474	0.00512	CbGeAlD
Regorafenib—KDR—thyroid gland—mediastinal cancer	0.00473	0.00511	CbGeAlD
Regorafenib—KIT—lymphoid tissue—mediastinal cancer	0.00462	0.00499	CbGeAlD
Regorafenib—ABL1—trachea—mediastinal cancer	0.00461	0.00498	CbGeAlD
Regorafenib—PDGFRB—lymphoid tissue—mediastinal cancer	0.00451	0.00487	CbGeAlD
Regorafenib—FLT4—lymph node—mediastinal cancer	0.00447	0.00483	CbGeAlD
Regorafenib—FGFR1—lymph node—mediastinal cancer	0.00441	0.00477	CbGeAlD
Regorafenib—ABL1—cardiac atrium—mediastinal cancer	0.00434	0.00468	CbGeAlD
Regorafenib—KDR—lung—mediastinal cancer	0.0043	0.00464	CbGeAlD
Regorafenib—CYP2C19—hematopoietic system—mediastinal cancer	0.00424	0.00458	CbGeAlD
Regorafenib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.00423	0.0571	CbGpPWpGaD
Regorafenib—KIT—bone marrow—mediastinal cancer	0.0042	0.00454	CbGeAlD
Regorafenib—KIT—thyroid gland—mediastinal cancer	0.00419	0.00453	CbGeAlD
Regorafenib—PDGFRB—bone marrow—mediastinal cancer	0.00411	0.00444	CbGeAlD
Regorafenib—PDGFRB—thyroid gland—mediastinal cancer	0.0041	0.00442	CbGeAlD
Regorafenib—PDGFRB—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00407	0.0549	CbGpPWpGaD
Regorafenib—ABL1—lymphoid tissue—mediastinal cancer	0.00402	0.00434	CbGeAlD
Regorafenib—RET—lymph node—mediastinal cancer	0.00395	0.00427	CbGeAlD
Regorafenib—KIT—lung—mediastinal cancer	0.00381	0.00411	CbGeAlD
Regorafenib—PDGFRB—lung—mediastinal cancer	0.00372	0.00402	CbGeAlD
Regorafenib—CYP2C8—hematopoietic system—mediastinal cancer	0.0037	0.004	CbGeAlD
Regorafenib—EPHA2—lymph node—mediastinal cancer	0.00369	0.00398	CbGeAlD
Regorafenib—ABL1—bone marrow—mediastinal cancer	0.00366	0.00395	CbGeAlD
Regorafenib—ABL1—thyroid gland—mediastinal cancer	0.00365	0.00394	CbGeAlD
Regorafenib—TEK—lymph node—mediastinal cancer	0.0036	0.00389	CbGeAlD
Regorafenib—FLT1—lymph node—mediastinal cancer	0.00348	0.00376	CbGeAlD
Regorafenib—RAF1—lymph node—mediastinal cancer	0.00346	0.00373	CbGeAlD
Regorafenib—CYP2B6—hematopoietic system—mediastinal cancer	0.00332	0.00359	CbGeAlD
Regorafenib—ABL1—lung—mediastinal cancer	0.00332	0.00358	CbGeAlD
Regorafenib—CYP2C9—hematopoietic system—mediastinal cancer	0.00329	0.00355	CbGeAlD
Regorafenib—PDGFRA—lymph node—mediastinal cancer	0.00326	0.00352	CbGeAlD
Regorafenib—CYP2B6—bronchus—mediastinal cancer	0.00299	0.00323	CbGeAlD
Regorafenib—KDR—lymph node—mediastinal cancer	0.00294	0.00318	CbGeAlD
Regorafenib—RAF1—Leptin signaling pathway—PTPN1—mediastinal cancer	0.00271	0.0365	CbGpPWpGaD
Regorafenib—KIT—lymph node—mediastinal cancer	0.00261	0.00281	CbGeAlD
Regorafenib—BRAF—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.0026	0.0351	CbGpPWpGaD
Regorafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPN1—mediastinal cancer	0.00257	0.0347	CbGpPWpGaD
Regorafenib—PDGFRB—lymph node—mediastinal cancer	0.00254	0.00275	CbGeAlD
Regorafenib—CYP3A4—hematopoietic system—mediastinal cancer	0.00251	0.00271	CbGeAlD
Regorafenib—CYP2B6—lymphoid tissue—mediastinal cancer	0.00234	0.00253	CbGeAlD
Regorafenib—ABCG2—bone marrow—mediastinal cancer	0.00231	0.00249	CbGeAlD
Regorafenib—ABCG2—thyroid gland—mediastinal cancer	0.0023	0.00249	CbGeAlD
Regorafenib—ABL1—lymph node—mediastinal cancer	0.00227	0.00245	CbGeAlD
Regorafenib—MAPK11—Insulin Signaling—PTPN1—mediastinal cancer	0.00216	0.0291	CbGpPWpGaD
Regorafenib—ABCG2—lung—mediastinal cancer	0.00209	0.00226	CbGeAlD
Regorafenib—PDGFRB—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.00202	0.0272	CbGpPWpGaD
Regorafenib—ABL1—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.00197	0.0265	CbGpPWpGaD
Regorafenib—CYP2B6—lung—mediastinal cancer	0.00193	0.00208	CbGeAlD
Regorafenib—RAF1—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.0018	0.0243	CbGpPWpGaD
Regorafenib—ABCB1—hematopoietic system—mediastinal cancer	0.00178	0.00192	CbGeAlD
Regorafenib—TEK—Hemostasis—PTPN1—mediastinal cancer	0.00167	0.0225	CbGpPWpGaD
Regorafenib—RAF1—Insulin Signaling—PTPN1—mediastinal cancer	0.00148	0.0199	CbGpPWpGaD
Regorafenib—ABCB1—trachea—mediastinal cancer	0.00144	0.00155	CbGeAlD
Regorafenib—ABCG2—lymph node—mediastinal cancer	0.00143	0.00154	CbGeAlD
Regorafenib—ABCB1—lymphoid tissue—mediastinal cancer	0.00125	0.00135	CbGeAlD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.00114	0.0154	CbGpPWpGaD
Regorafenib—ABCB1—bone marrow—mediastinal cancer	0.00114	0.00123	CbGeAlD
Regorafenib—ABCB1—thyroid gland—mediastinal cancer	0.00114	0.00123	CbGeAlD
Regorafenib—ABCB1—lung—mediastinal cancer	0.00103	0.00111	CbGeAlD
Regorafenib—RAF1—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000944	0.0127	CbGpPWpGaD
Regorafenib—ABCB1—lymph node—mediastinal cancer	0.000705	0.000762	CbGeAlD
Regorafenib—FLT4—Signaling Pathways—PTPN1—mediastinal cancer	0.000682	0.00919	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—PTPN1—mediastinal cancer	0.000643	0.00867	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—PTPN1—mediastinal cancer	0.000588	0.00793	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—PTPN1—mediastinal cancer	0.000509	0.00686	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—PTPN1—mediastinal cancer	0.00045	0.00607	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—PTPN1—mediastinal cancer	0.000413	0.00557	CbGpPWpGaD
Regorafenib—KIT—Immune System—PTPN1—mediastinal cancer	0.000406	0.00547	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PTPN1—mediastinal cancer	0.000385	0.00519	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PTPN1—mediastinal cancer	0.000384	0.00518	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PTPN1—mediastinal cancer	0.000358	0.00483	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PTPN1—mediastinal cancer	0.000346	0.00467	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PTPN1—mediastinal cancer	0.000338	0.00456	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PTPN1—mediastinal cancer	0.000337	0.00455	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PTPN1—mediastinal cancer	0.000308	0.00416	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PTPN1—mediastinal cancer	0.000291	0.00392	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PTPN1—mediastinal cancer	0.000288	0.00389	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTPN1—mediastinal cancer	0.000267	0.0036	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTPN1—mediastinal cancer	0.000262	0.00354	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTPN1—mediastinal cancer	0.000249	0.00336	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTPN1—mediastinal cancer	0.000248	0.00335	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTPN1—mediastinal cancer	0.000224	0.00302	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTPN1—mediastinal cancer	0.000199	0.00269	CbGpPWpGaD
